Maccura Competitors

300463 Stock

13.84 0.72 4.95%

Maccura Biotechnology competes with Bloomage Biotechnology, Jinhe Biotechnology, Guangdong Marubi, and Guangzhou KingTeller; as well as few others. The company operates under Life Sciences Tools & Services sector and is part of Health Care industry. Analyzing Maccura Biotechnology competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Maccura Biotechnology to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Maccura Biotechnology Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Maccura Biotechnology competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
10.51	13.83	17.15

Details

Intrinsic

Valuation

Low	Real	High
8.24	11.56	14.88

Details

Naive

Forecast

Low	Next	High
11.10	14.43	17.75

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
13.25	14.30	15.35

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Maccura Biotechnology. Your research has to be compared to or analyzed against Maccura Biotechnology's peers to derive any actionable benefits. When done correctly, Maccura Biotechnology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Maccura Biotechnology.

Maccura Biotechnology Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Maccura Biotechnology and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Maccura and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Maccura Biotechnology does not affect the price movement of the other competitor.

	688363	002688	300463	603983	002177	002516	600545
688363		0.82	0.91	0.87	0.8	0.69	0.72	688363
002688	0.82		0.84	0.87	0.94	0.96	0.93	002688
300463	0.91	0.84		0.91	0.8	0.73	0.75	300463
603983	0.87	0.87	0.91		0.83	0.81	0.79	603983
002177	0.8	0.94	0.8	0.83		0.92	0.96	002177
002516	0.69	0.96	0.73	0.81	0.92		0.95	002516
600545	0.72	0.93	0.75	0.79	0.96	0.95		600545
	688363	002688	300463	603983	002177	002516	600545

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Maccura Stock performing well and Maccura Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Maccura Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
688363	3.03	0.43	0.06	(0.84)	3.50	(3.45)	11.37	(4.80)	34.68
002688	1.69	0.29	0.06	(0.63)	1.82	(1.95)	4.05	(3.46)	11.97
300463	2.22	0.43	0.09	(0.72)	2.44	(2.58)	6.28	(3.75)	22.67
603983	2.27	0.58	0.16	(2.32)	2.24	(2.60)	5.93	(5.13)	15.94
002177	3.15	0.58	0.11	1.38	3.94	(3.22)	8.64	(6.63)	20.03
002516	2.36	0.63	0.17	(5.31)	2.26	(2.67)	8.28	(4.01)	16.92
600545	2.75	0.58	0.15	10.29	2.69	(3.52)	7.47	(4.11)	20.24

Unable to evaluate fundamental data of [688363.SHG, 002688.SHE, 300463.SHE, 603983.SHG, 002177.SHE, 002516.SHE, 600545.SHG] at this time. Please try again later

All Fundamental Data

Maccura Biotechnology Competitive Analysis

The better you understand Maccura Biotechnology competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Maccura Biotechnology's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Maccura Biotechnology's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	300463	688363	002688	603983	002177	002516	600545
	4.95 13.84 Maccura	5.46 57.50 Bloomage	3.52 4.38 Jinhe	6.77 27.68 Guangdong	0.21 4.80 Guangzhou	4.35 5.28 Kuangda	1.50 1.97 Saurer
Market Volatility (90 Days Market Risk)	Somewhat reliable	Very steady	Slightly risky	Not too volatile	Relatively risky	Moderately volatile	Very risky
Market Performance (90 Days Performance)	OK	Modest	Good	Solid	Good	Good	Good
Odds of Financial Distress (Probability Of Bankruptcy)	Very Low	Low	About Average	Very Low	Low	Very Low	Below Average
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Fairly Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Cautious Hold	Hold	Cautious Hold
Net Asset	8.12 B	8.47 B	5.45 B	4.45 B	1.73 B	4.42 B	9.89 B
Profit Margin	0.12 %	0.08 %	0.04 %	0.12 %	0.77 %	0.08 %	(0.03) %
EBITDA	613.34 M	664.83 M	387.55 M	277.35 M	16.08 M	328.98 M	46.84 M
Operating Margin	0.17 %	0.06 %	0.13 %	0.10 %	0.03 %	0.14 %	0.01 %
Current Valuation	8.75 B	29.06 B	4.98 B	10.31 B	3.25 B	7.16 B	5.44 B
Price To Book	1.37 X	4.17 X	1.51 X	3.53 X	2.15 X	2.14 X	1.11 X
Retained Earnings	3.84 B	2.45 B	560.1 M	1.99 B	811.2 M	787.71 M	209.82 M
Beta	0.38	0.87	0.41	0.21	1.04	0.59	0.32
Number Of Employees	3.36 K	4.66 K	2.32 K	1.1 K	199	1.87 K	3.18 K
Shares Outstanding	612.47 M	481.68 M	771.69 M	401 M	761.19 M	1.47 B	1.79 B
Cash Flow From Operations	901.51 M	699.65 M	198.77 M	338.02 M	25 M	216.73 M	333.78 M
Annual Yield	0.01 %	N/A	0.02 %	N/A	0 %	0.02 %	N/A
Total Debt	144.65 M	153.13 M	2.3 B	100.07 M	33.41 M	777.23 M	1.13 B
Return On Equity	0.0485	0.062	0.0371	0.1	0.0377	0.0407	-0.0335
Return On Asset	0.0219	0.0319	0.0223	0.039	3.0E-4	0.0308	-0.0031
Book Value Per Share	10.79 X	14.67 X	2.96 X	8.42 X	2.23 X	2.48 X	1.78 X
Total Asset	8.12 B	8.47 B	5.45 B	4.45 B	1.73 B	4.42 B	9.89 B
Target Price	13.79	56.46	N/A	31.19	18.14	8.25	N/A
Last Dividend Paid	0.15	0.38	0.1	0.52	0.01	0.1	N/A
Shares Owned By Institutions	4.76 %	16.56 %	1.23 %	7.46 %	1.30 %	1.10 %	3.67 %
Market Capitalization	8.8 B	28.01 B	3.38 B	11.32 B	3.65 B	7.77 B	3.52 B
Price To Sales	3.22 X	4.89 X	1.49 X	4.29 X	45.15 X	3.73 X	0.77 X
Net Income	312.62 M	592.56 M	86.46 M	259.42 M	15.45 M	191.2 M	35.79 M
Earnings Per Share	0.53 X	0.91 X	0.12 X	0.82 X	0.02 X	0.12 X	(0.07) X
Shares Owned By Insiders	40.27 %	61.00 %	45.62 %	80.79 %	20.40 %	54.55 %	53.93 %
Revenue	2.9 B	6.08 B	2.17 B	2.23 B	70.06 M	1.8 B	6.02 B
Working Capital	3.1 B	1.9 B	(217.74 M)	1.52 B	483.78 M	1.65 B	1.66 B
Gross Profit	1.96 B	6.36 B	613.79 M	1.14 B	47.97 M	238.4 M	850.65 M
Day Typical Price	14.09	58.35	4.44	28.11	4.92	5.38	2.01
Accumulation Distribution	0.0514	0.0425	0.0501	0.0563	0.11	0.0642	0.0529
Market Facilitation Index	0.75	2.55	0.23	1.64	0.58	0.36	0.11
Daily Balance Of Power	(0.96)	(1.30)	(0.70)	(1.23)	0.0172	(0.67)	(0.27)
Period Momentum Indicator	(0.72)	(3.32)	(0.16)	(2.01)	0.01	(0.24)	(0.03)
Rate Of Daily Change	0.95	0.95	0.96	0.93	1.0	0.96	0.99
Day Median Price	14.22	58.78	4.47	28.32	4.98	5.43	2.03
Price Action Indicator	(0.74)	(2.93)	(0.18)	(1.65)	(0.18)	(0.27)	(0.07)
Relative Strength Index	57.71	58.26	69.09	62.45	84.66	87.74	76.21
Coefficient Of Variation	873.94	1255.12	886.69	555.43	648.68	528.76	611.21
Mean Deviation	2.22	3.03	1.69	2.27	3.15	2.36	2.75
Jensen Alpha	0.432	0.4323	0.2881	0.5798	0.5811	0.6305	0.5769
Total Risk Alpha	(0.15)	(0.39)	(0.11)	0.0603	(0.02)	0.0948	0.0122
Sortino Ratio	0.0907	0.0626	0.0599	0.1598	0.1123	0.1729	0.1455
Downside Variance	7.57	16.9	4.08	7.25	21.12	8.22	10.13
Standard Deviation	3.32	4.87	2.23	3.12	4.2	3.31	3.63
Kurtosis	5.3	5.33	0.9937	1.44	0.5614	1.5	1.34
Potential Upside	6.28	11.37	4.05	5.93	8.64	8.28	7.47
Treynor Ratio	(0.72)	(0.84)	(0.63)	(2.32)	1.38	(5.31)	10.29
Maximum Drawdown	22.67	34.68	11.97	15.94	20.03	16.92	20.24
Variance	11.05	23.74	4.98	9.71	17.61	10.97	13.17
Market Risk Adjusted Performance	(0.71)	(0.83)	(0.62)	(2.31)	1.39	(5.30)	10.3
Risk Adjusted Performance	0.0954	0.0695	0.0931	0.1456	0.1264	0.1527	0.1334
Skewness	1.17	0.7387	0.5632	0.5204	(0.20)	0.7385	0.4506
Semi Deviation	2.44	3.5	1.82	2.24	3.94	2.26	2.69
Information Ratio	0.0751	0.0528	0.0542	0.1381	0.123	0.1496	0.1276
Value At Risk	(3.75)	(4.80)	(3.46)	(5.13)	(6.63)	(4.01)	(4.11)
Expected Short fall	(2.58)	(3.45)	(1.95)	(2.60)	(3.22)	(2.67)	(3.52)
Downside Deviation	2.75	4.11	2.02	2.69	4.6	2.87	3.18
Semi Variance	5.96	12.28	3.31	5.04	15.55	5.1	7.21

Maccura Biotechnology Competition Performance Charts

Five steps to successful analysis of Maccura Biotechnology Competition

Maccura Biotechnology's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Maccura Biotechnology in relation to its competition. Maccura Biotechnology's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Maccura Biotechnology in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Maccura Biotechnology's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Maccura Biotechnology, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Maccura Biotechnology position

In addition to having Maccura Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Gambling Thematic Idea Now

Gambling

Companies that are related to providing gambling services across multiple geographical areas by investing, exploring, or producing software, hardware, and related infrastructure for running gambling operations or trading speculative assets. The Gambling theme has 38 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gambling Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Maccura Stock

Maccura Biotechnology financial ratios help investors to determine whether Maccura Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Maccura with respect to the benefits of owning Maccura Biotechnology security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Maccura Competitors

Specify up to 10 symbols:

Maccura Biotechnology Competition Correlation Matrix

Risk-Adjusted Indicators

Maccura Biotechnology Competitive Analysis

Maccura Biotechnology Competition Performance Charts

Five steps to successful analysis of Maccura Biotechnology Competition

Complement your Maccura Biotechnology position

Did You Try This Idea?

Run Gambling Thematic Idea Now

Gambling

Other Information on Investing in Maccura Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY